UK CMA opens phase‑2 probe into AkzoNobel‑Axalta $25 bn merger
Britain’s Competition and Markets Authority (CMA) has launched a phase‑2 investigation into the $25 billion merger of AkzoNobel and Axalta, citing concerns that the combined company could dominate the UK vehicle‑refinish coatings market. The regulator gave the parties until 18 November to propose remedies, warning that failure to do so could trigger a full investigation. AkzoNobel and Axalta said they will use the same divestiture remedy previously accepted by the European Commission and remain confident of completing the deal by early 2027.
Why it matters
The CMA’s probe could delay or alter the merger, creating regulatory risk for both companies and potentially affecting their stock valuations. The deadline to submit remedies adds pressure to reach an agreement before a full investigation begins.
Key facts
- 1The CMA raised competition concerns about the $25 billion AkzoNobel‑Axalta merger. investing.com
- 2The regulator set a deadline of 18 November for the companies to propose remedies. investing.com
- 3The combined entity would control 40% to 50% of the UK vehicle‑refinish coatings market. investing.com
- 4AkzoNobel and Axalta plan to address the concerns with the same remedy proposal accepted by the European Commission. investing.com
- 5Both companies expect to complete the merger by early 2027. investing.com
- 6The CMA announced a phase‑2 probe into the merger. rttnews.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.